The largest drug
discovery company
in the CEE region


Your integrated drug
discovery partner of choice


Developing breakthrough
therapies in oncology


Delivering comprehensive
research solutions to biotech
and pharma


News See all

Selvita opens new research site in Poznan

Krakow, Poland – 10 May 2017 – Selvita (WSE:SLV), one of the largest drug discovery companies in Europe, has opened...

Selvita presents at BioTrinity 2017

Kraków, Poland - 04 May 2017 - Selvita will participate, as well as present, at the upcoming BioTrinity 2017 conference,...

Selvita shows 19% business growth in 2016

Krakow, Poland – 20 April 2017 – Selvita, one of the largest drug discovery companies in Europe, has published annual...

Selvita researchers publish new paper on CDK8 inhibitor SEL120…

Krakow, Poland – April 07, 2017 - Selvita, a clinical stage drug discovery and development company focused on innovative medicines...

Selvita and Menarini Group Announce Global License Agreement for…

Krakow/Berlin, March 28, 2017 – Selvita S.A. (WSE:SLV), and Berlin-Chemie Menarini, a company of the Menarini Group, announced today that...

About Selvita

Selvita has two primary focus areas:

– to serve the drug discovery market as a customer centric provider of high quality, integrated drug discovery services and

– as a drug discovery company engaged in the research and development of breakthrough therapies in oncology.


Drug Discovery Services

Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries.

We offer drug discovery support at every stage of the early discovery phase up to the preclinical research phase.


REsearch and Development

Selvita is actively engaged in the discovery and development of breakthrough medicines primarily in the area of oncology. 

Our most advanced project is about to enter the clinic in Q4 2016.


Investor Relations SLV -0.55 (-0.95%)

Share price 2017-05-26 14:39:07

57.61 PLN More


We are a multicultural and a multinational company employing professionals from all over the world.

Find out who we’re courrently looking for and what we can offer our employees.